Scientific publications

GMP Manufacturing

03-09-20
Vaccine
First-in-human administration of a live-attenuated RSV vaccine lacking the G-protein assessing safety, tolerability, shedding and immunogenicity: a randomized controlled trial
Pauline Verdijk , Johan L van der Plas, Emilie M J van Brummelen, Rienk E Jeeninga, Cornelis A M de Haan, Meta Roestenberg, Jacobus Burggraaf , Ingrid M C Kamerling
pubmed.ncbi.nlm.nih.gov
22-09-14
Vaccine
Reactogenicity and immunogenicity of inactivated poliovirus vaccine produced from Sabin strains: a phase I Trial in healthy adults in Cuba
Sonia Resik , Alina Tejeda, Magilé Fonseca, Nilda Alemañi, Manuel Diaz, Yenisleidys Martinez, Gloria Garcia, Hiromasa Okayasu, Anthony Burton , Wilfried A M Bakker, Pauline Verdijk, Roland W Sutter
www.pubmed.ncbi.nlm.nih.gov
03-09-14
Vaccine
Safety and immunogenicity of a primary series of Sabin-IPV with and without aluminum hydroxide in infants
Pauline Verdijk, Nynke Y Rots, Monique G C T van Oijen, William C Weldon, M Steven Oberste, Hiromasa Okayasu, Roland W Sutter, Wilfried A M Bakker
www.pubmed.ncbi.nlm.nih.gov

You can send us an email:
info@intravacc.nl

Reach out to Business Development:
BD@intravacc.nl

Or pick up the phone:
+31 30 792 03 00

You can also just fill out the contact form on the right.

We look forward to hearing from you!